文献速递血液净化与透析肾移植

澳大利亚透析与移植女性围产结局的决定因素

Determinants of Perinatal Outcomes in Dialyzed and Transplanted Women in Australia.
PubMed 文献 · Kidney Int Rep · 2022-03-23

该研究链接ANZDATA与围产数据集(1991-2013),分析接受慢性肾脏替代治疗(KRT)的澳大利亚女性≥20周妊娠的围产结局。248例KRT母亲所生婴儿(移植211例、透析37例)活产率≥94%;透析、移植、非KRT队列围产期死亡率分别为162/1000、62/1000、9/1000。KRT暴露婴儿早产、小于胎龄儿、出生状态差、复苏、重症监护入院及住院时间长的风险升高,透析队列结局更差。

要点

  • 透析、移植、非KRT队列围产期死亡率分别为162/1000、62/1000、9/1000。
  • KRT暴露婴儿早产、SGA、复苏、ICU入院及长住院风险升高,透析队列更差。
  • 移植女性即使血清肌酐≤120 μmol/l,早产和低出生体重风险仍升高。

核心结论

  • 母亲透析和移植导致围产期发病率增加,早产儿尤为明显,即使孕前移植肾功能良好者亦如此。
  • 妊娠期高血压不是围产期发病的主要决定因素。
  • 肾脏病女性的孕前咨询应包括围产期并发症的讨论。

研究设计与样本

  • 链接澳大利亚与新西兰透析和移植登记处(ANZDATA)与围产数据集(1991-2013年),分析澳大利亚接受慢性KRT女性≥20周妊娠的围产结局。
  • 按母亲KRT暴露分层(透析或移植,分别分析),共纳入2,948,084名婴儿(1,628,181名母亲)。
  • 其中248名婴儿的母亲接受KRT(移植n=211;透析n=37)。

主要发现

  • 透析、移植、非KRT队列的活产率均≥94%;围产期死亡率分别为162/1000、62/1000、9/1000。
  • KRT暴露婴儿早产、小于胎龄儿、出生状态差、复苏、重症监护入院及住院时间长的 odds 增加,透析队列结局更差。
  • 透析和移植母亲的早产儿(与非KRT暴露早产儿相比)所有不良结局的 odds 升高1.6至2.7倍,但出生体重<2500 g在透析队列升高11倍。
  • 校正分析中,移植女性即使同种异体肾功能较好(血清肌酐≤120 μmol/l),早产和低出生体重的 odds 仍升高>10倍,其他不良结局的 odds 升高1.8至4.6倍。
  • 在移植女性中,中介分析显示妊娠期高血压仅贡献较小的比例效应(2.5%-11.2%)。

临床怎么用

  • 作者认为,肾脏病女性的孕前咨询应包括围产期并发症的讨论。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Drivers of adverse perinatal outcomes in pregnancies of women receiving chronic kidney replacement therapy (KRT) remain poorly understood. METHODS: Births ≥ 20 weeks of gestation in Australian women receiving KRT were analyzed for perinatal outcomes stratified by maternal KRT exposure (dialysis or transplant, analyzed separately), by linking the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) and perinatal data sets (1991-2013). RESULTS: Of 2,948,084 babies (1,628,181 mothers), 248 were born to mothers receiving KRT (transplant, n = 211; dialysis, n = 37), with live birth rates ≥ 94%. The perinatal death rate was 162, 62, and 9 per 1000 births in the dialysis, transplant, and non-KRT cohorts, respectively. Babies exposed to KRT had increased odds of prematurity, small-for-gestational age (SGA), poor birth condition, resuscitation, intensive care admission, and longer hospitalization, with the dialysis cohort having worse outcomes. Preterm babies of dialyzed and transplanted mothers (compared with preterm babies with no KRT exposure) experienced 1.6- to 2.7-fold higher odds for all adverse outcomes, except birthweight < 2500 g, which was 11-fold higher for the dialysis cohort. In adjusted analyses, transplanted women with better allograft function (serum creatinine ≤ 120 μmol/l) still had >10-fold higher odds of preterm birth and low birthweight and 1.8- to 4.6-fold increased odds of other adverse outcomes. In transplanted women, mediation analysis revealed that pregnancy-induced hypertension contributed only a modest proportional effect (2.5%-11.2%) on adverse outcomes. CONCLUSION: Maternal dialysis and transplantation conferred excess perinatal morbidity, particularly for preterm babies, and even in women with good preconception allograft function. Pregnancy-induced hypertension is not the predominant determinant of perinatal morbidity. Preconception counseling of women with kidney disease should encompass discussion of perinatal complications.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Hewawasam E, Davies CE, Li Z, et al. Determinants of Perinatal Outcomes in Dialyzed and Transplanted Women in Australia. Kidney Int Rep. 2022. PMID: 35685315. doi:10.1016/j.ekir.2022.03.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。